Floreat Medica Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.96 M
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.09 Cr
- Revenue Growth 32.62%
- Profit Growth 277.64%
- Ebitda 128.25%
- Net Worth 6.73%
- Total Assets 0.79%
About Floreat Medica
Floreat Medica Private Limited (FMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 March 2007 and has a history of 17 years and ten months. Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.96 M.
The company currently has active open charges totaling ₹3.09 Cr.
Narayanan Sureshkumar, Anil David, Haridasan Varikkol, and Two other members serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239KL2007PTC020510
-
Company No.
020510
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Mar 2007
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Floreat Medica?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaiprampadan Joy
|
Managing Director | 19-Mar-2007 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Biju Kumaran
|
Director | 19-Mar-2007 | Current |
|
Narayanan Sureshkumar
|
Director | 19-Mar-2007 | Current |
|
Anil David
|
Director | 19-Mar-2007 | Current |
|
Haridasan Varikkol
|
Director | 19-Mar-2007 | Current |
Financial Performance of Floreat Medica.
Floreat Medica Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.62% increase. The company also saw a substantial improvement in profitability, with a 277.64% increase in profit. The company's net worth moved up by a moderate rise of 6.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Floreat Medica?
In 2021, Floreat Medica had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹30.94 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.08 Cr
- Axis Bank Limited : 0.51 Cr
- Others : 0.30 Cr
- State Bank Of Travancore : 0.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2023 | State Bank Of India | ₹4.10 M | Open |
| 04 Nov 2023 | Others | ₹0.53 M | Open |
| 20 Jan 2023 | Others | ₹0.53 M | Open |
| 25 Oct 2022 | State Bank Of India | ₹3.20 M | Open |
| 22 Dec 2021 | Axis Bank Limited | ₹2.00 M | Open |
How Many Employees Work at Floreat Medica?
Floreat Medica has a workforce of 45 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Floreat Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Floreat Medica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
